Login / Signup

The detection of circulating tumor cells indicates poor therapeutic efficacy and prognosis in patients with nonsmall cell lung cancer: A systematic review and meta-analysis.

Shan WangXiaolin LiuHongwei LvJing YuHuihui Li
Published in: Journal of evidence-based medicine (2024)
CTCs can be used as a biomarker to monitor NSCLC efficacy, predict prognosis and guide follow-up treatment.
Keyphrases
  • circulating tumor cells
  • circulating tumor
  • small cell lung cancer
  • single cell
  • cell therapy
  • loop mediated isothermal amplification
  • combination therapy
  • label free
  • replacement therapy
  • brain metastases